I. A. Klenina

I. A. Klenina

Auto-generated profile, based on publicly available information

I. A. Klenina

State Institution “Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine”, Dnipro, Ukraine

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2025 in GASTROENTEROLOGY
Verified
Journal Article
Open access
PDF file
YSYu.M. Stepanov
Yu.M. Stepanov
VDV.I. Didenko
V.I. Didenko
IKI.A. Klenina
I.A. Klenina
OTO.M. Tatarchuk
O.M. Tatarchuk
OPO.P. Petishko
O.P. Petishko
RKR.M. Kyslova
R.M. Kyslova
Background. The intestinal microbiota and its metabolites have a significant impact on the pathophy­siology of liver diseases, it plays an important role in human metabolism, supports the intestinal mucosal barrier and interacts with the immune system. The COVID-19 epidemic has led to a significant increase in the number of patients in Ukraine suffering from metabolic dysfunction-associated steatotic liver disease (MASLD). One of the unresolved problems associated with MASLD is the identification of pathogenetic links that affect the risk of rapid progression of the disease and the development of irreversible changes in the liver. An imbalance in the intestinal microbiota is a trigger for the launch of a pathological reaction in the liver. The purpose: to study the features of the content of pro- and anti-inflammatory cytokines and short-chain fatty acids in MASLD in patients with an immune response to SARS-CoV-2 depending on the small intestinal bacterial overgrowth (SIBO). Materials and methods. The study included 61 patients with MASLD, 41 men and 20 women aged 18 to 73 years, mean age (46.4 ± 1.5) years. All patients underwent determination of IgG specific to SARS-CoV-2, cytokine content (IL-6, IL-10, TNF-α) in serum by enzyme-linked immunosorbent assay. For the diagnosis of SIBO, a hydrogen breath test (HBT) with glucose was performed. Evaluation of short-chain fatty acids in faeces was performed on a chromatograph using the Guohua Zhao method. Results. In 44.3 % of patients with MASLD and an immune response to SARS-CoV-2, SIBO was diagnosed. The median value of IL-6 level in SIBO significantly exceeded the control values by 13.7 times (p < 0.001), the median of TNF-α was significantly higher by 18.5 times (p < 0.001). In SIBO group, the levels of TNF-α and IL-6 were, accordingly, 2 (p = 0.01) and 3.3 times (p = 0.004) higher compared to patients without SIBO. The median acetic acid (C2) level in the group with SIBO statistically significantly excee­ded the control value by 1.5 times (p = 0.021). The median concentration of propionic acid (C3) was significantly higher by 1.4 times (p = 0.003) in the faeces of patients with SIBO than in those without it. At the same time, in the presence of SIBO, a decrease in the median of butyric acid (C4) was observed by 2.2 times (p = 0.021) compared to the group of patients without SIBO. Direct correlations were found between the levels of IgG specific to SARS-CoV-2 and TNF-α (r = 0.304, p = 0.016); the HBT index at 45 min and the level of TNF-α (r = 0.269, p = 0.041), IL-6 (r = 0.443, p = 0.002), the median of propionic acid (C3) content (r = 0.400, p = 0.006). At the same time, an inverse correlation was found between the level of butyric acid (C4) and the HBT index at 60 min (r = –0.332, p = 0.040). Conclusions. In patients with MASLD with an immune response to SARS-CoV-2 and SIBO, there was a significant increase in the production of proinflammatory cytokines, in contrast to patients without SIBO. An increased content of acetic acid and a decrease in butyric acid in the faeces of patients with MASLD with an immune response to SARS-CoV-2 in the presence of SIBO were found. Disturbance in the microbial composition of the small intestinal microbiota, hyperproduction of proinflammatory cytokines and impaired synthesis of short-chain fatty acids are distinctive features of MASLD in patients with an immune response to SARS-CoV-2.

29 March 2024 in GASTROENTEROLOGY
Verified
Journal Article
Open access
PDF file
YSYu.M. Stepanov
Yu.M. Stepanov
LML.M. Mosiychuk
L.M. Mosiychuk
IKI.A. Klenina
I.A. Klenina
ОTО.м. Tatarchuk
О.м. Tatarchuk
OPO.P. Petishko
O.P. Petishko
OSO.M. Shevtsova
O.M. Shevtsova
Background. In Ukraine, metabolic syndrome remains one of the most important problems of family medicine, it contributes to an increase in the prevalence of digestive diseases. Among the components of metabolic syndrome, researchers consider visceral obesity to be the most prognostically unfavo­rable. The purpose is to optimize diagnostic approaches to the formation of a risk group for the detection of visceral obesity in gastroenterology patients. Materials and methods. Eighty patients with gastrointestinal diseases were examined, 56 men (70.0 %) and 24 women (30.0 %). The age of the patients ranged from 18 to 66 years, with an average of (39.04 ± 1.03) years. TANITA MC-780MA body composition analyzer scales (Japan) were used to assess body structure. In all patients, serum levels of glucose, insulin, leptin, total cholesterol, triglycerides (TG), high-density lipoprotein cholesterol (HDL-C) were determined, as well as low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), atherogenicity coefficient (AC) and homeostasis model assessment of insulin resistance (HOMA-IR). Results. Gastroenterological patients with visce­ral obesity had more pronounced changes in lipid and carbohydrate metabolism, which were characterized by a decrease in the content of HDL-C by 16.3 % (p < 0.05), an increase in TG by 41.9 % (p < 0.001), VLDL-C by 41.7 % (p < 0.01), AС by 41.6 % (p < 0.01), HOMA-IR by 28.0 % (p < 0.01) compared to patients without visceral obesity. According to the results of the correlation analysis, functional relationships were found between the amount of visceral fat and the level of leptin (r = 0.37; р = 0.0008), insulin (r = 0.41; р = 0.001), HOMA-IR (r = 0.48; р = 0.00001), TG (r = 0.452; р = 0.017), LDL-C (r = 0.383; р = 0.016), AС (r = 0.566; p < 0.001), TG/glucose ratio (r = 0.27; p = 0.0181), HDL-C (r = –0.448; p = 0.004). Determined predictors for the development of visceral obesity were as follows: triglycerides/high-density lipoprotein ratio (odds ratio (OR) 1.32; p = 0.0001), triglycerides/glucose ratio (OR 1.17; p = 0.0014), HOMA-IR (OR 1.26; p = 0.0013), atherogenicity coefficient (OR 1.13; p = 0.0001), leptin/triglycerides ratio (OR 1.35; p = 0.0014). Conclusions. The formation of a risk group for the detection of visceral obesity with the help of defined diagnostic criteria will allow to personalize the management of gastroenterology patients already at the primary level of medical care.

29 March 2024 in GASTROENTEROLOGY
Verified
Journal Article
Open access
PDF file
YSYu.M. Stepanov
Yu.M. Stepanov
VDV.I. Didenko
V.I. Didenko
IKI.A. Klenina
I.A. Klenina
OTO.M. Tatarchuk
O.M. Tatarchuk
OPO.P. Petishko
O.P. Petishko
Background. It is known that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can directly infect hepatocytes. At the same time, overweight and obesity are surrogate markers of the adverse effects of coronavirus disease 2019 (COVID-19). The purpose of the study: to evaluate changes in lipid and carbohydrate metabolism and their indices in the serum of patients with non-alcoholic fatty liver disease (NAFLD) with an immune response to SARS-CoV-2. Materials and methods. We studied 37 patients with NAFLD who had IgG to SARS-CoV-2. All patients were divided into two groups: group I consisted of 19 participants who were PCR-negative for SARS-CoV-2, group II included 18 patients who had COVID-19, as confirmed by PCR testing. The content of total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), glucose, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol (VLDL-C), atherogenicity coefficient, insulin resistance indices (HOMA-IR), TG to glucose (TG/Gly) and TG to HDL-C (TG/HDL-C) ratio were assessed in all patients. Results. Among patients with NAFLD with an immune response to SARS-CoV-2, dyslipidemia manifested by a probable increase in the median TG content in groups I and II by 2.5 and 3.4 times (р = 0.0001), respectively; TC — by 1.2 times (р = 0.0425) in both groups, with a tendency to increase; VLDL-C — by 1.8 (р = 0.010) and 2.5 times (р = 0.0022), respectively, and a decrease in the median content of HDL-C by 1.7 (р = 0.0016) and 1.9 times (р = 0.0008), respectively, in blood serum. The identified changes led to a statistically significant increase in the median atherogenicity coefficient in groups I and II — by 2.2 (р = 0.0036) and 2.5 times (р = 0.007). An increase in the HOMA-IR did not have a statistically significant difference between the groups: in group I, this index increased by 3.1 times (p < 0.05) compared with the controls, in group II — by 3 times (p < 0.05). In addition, patients in both groups had a statistically significant increase in TG/Gly and TG/HDL-C ratio compared to controls. However, the detected changes were more pronounced in group II, where TG/Gly and TG/HDL-C levels were 1.5 (р = 0.038) and 1.9 times (р = 0.035), respectively, higher than in group I. Conclusions. Patients with an immune response to SARS-CoV-2 with NAFLD have disorders of lipid and carbohydrate metabolism. At the same time, the signs of dyslipidemia were more pronounced in participants with a history of SARS-CoV-2. TG/Gly and TG/HDL-C ratio should be included in the diagnostic algorithm for assessing insulin resistance in patients with COVID-19 who are overweight or obese.

29 December 2022 in Medicni perspektivi
Verified
Journal Article
Open access
PDF file
YSYu.M. Stepanov
Yu.M. Stepanov
VDV.I. Didenko
V.I. Didenko
IKI.A. Klenina
I.A. Klenina
OTO.M. Tatarchuk
O.M. Tatarchuk
OPO.P. Petishko
O.P. Petishko
The aim of our research was to obtain new minimally invasive serum markers of fibrotic changes of liver in patients with chronic diffuse liver diseases of different etiology and compare them with traditional markers. 364 patients aged 30 to 66 years were examined: 221 women (60.7%) and 143 men (39.3%). Depending on the etiological factors, all patients were divided into 4 groups: group I consisted of 108 patients with non-alcoholic fatty liver disease (NAFLD), group II – 143 patients with chronic hepatitis associated with virus C (CHC), group III – 56 patients with alcoholic liver disease (ALD), group IV – 57 patients with toxic drug-induced hepatitis (TH). The control group consisted of 30 practically healthy people. Using correlation and ROC-analyzes, we obtained minimally invasive diagnostics markers that show the risk of developing liver fibrosis. For patients with NAFLD these were the levels of HOMA-IR, TNFα/IL-10 and α1-acid glycopeptide content, which are better in quality of the diagnostic model than the traditional Forns index, APRI, FIB-4, AAR. For patients with CHC, these were the protein-bound hydroxyproline (HPp/b) /HPf ratio, phospholipids content, and IL-6, CD4+ levels, which are better diagnostic models than the traditional Forns index, APRI, FIB-4, AAR. The following markers were obtained for patients with ALD – TNFα levels, HPp/b and glycosaminoglycans content, which are better diagnostic models than the traditional Forns index, APRI, FIB-4, AAR. For patients with TH, these were medium molecular weight peptides content, IL-6/IL-10 ratio and CD4+/CD8+, which are better diagnostic models than the traditional Forns index, APRI, FIB-4, AAR. Thus, new minimally invasive markers of fibrosis in patients with chronic diffuse liver diseases have been obtained.

27 June 2025 in GASTROENTEROLOGY
Verified
Journal Article
Open access
PDF file
VDV.I. Didenko
V.I. Didenko
SMS.L. Melanich
S.L. Melanich
IKI.A. Klenina
I.A. Klenina
OTO.M. Tatarchuk
O.M. Tatarchuk
OPO.P. Petishko
O.P. Petishko
HBH.I. Bocharov
H.I. Bocharov
Background. The detrimental interaction of complex inflammatory pathways, which are chronically present in metabolic-associated steatotic liver disease (MASLD), can be dramatically exacerbated in the setting of COVID-19, contributing to the development of liver fibrosis. To date, there is no consensus on the use of serum parameters instead of liver biopsy as criteria for predicting the unfavorable course of MASLD in patients with an immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The purpose of the study was to optimize the diagnosis and management of patients with MASLD and an immune response to SARS-CoV-2 by identifying predictors of adverse outcome. Materials and methods. The study included 105 patients with MASLD who had an elevated level of IgG antibodies specific to SARS-CoV-2 of more than 40 BAU/ml compared to the control value, which allowed us to conclude that these patients had an immune response. The stiffness of the liver parenchyma was assessed by shear wave elastography (SWE) using an expert-class ultrasound scanner Soneus P7 (Ultrasign, Ukraine, Switzerland). All patients’ serum parameters of immunological profile, liver function, and prothrombotic environment were determined. The results were statistically analyzed using the Statistica 10 software package. Results. According to the results of SWE, 49 (46.7 %) patients had no liver fibrosis, 40 (38.1 %) were diagnosed with mild fibrosis (5.79–7.5 kPa) with an average value of (6.08 ± 0.13) kPa, and 16 (15.2 %) had moderate fibrosis (7.5–10.0 kPa) with an average value of (7.65 ± 0.38) kPa. In patients with unfavorable course of MASLD, the level of aspartate aminotransferase was (50.1 ± 14.9) U/L and was 2 times higher than in the control group — (23.4 ± 10.3) U/L (p < 0.001) and in patients without liver fibrosis — (27.0 ± 9.1) U/L (p < 0.001). In the development of unfavorable course of MASLD in patients with an immune response to SARS-CoV-2, the mean platelet volume increased by 11 % (p < 0.001) compared to the controls and group without liver fibrosis. Similar changes were found when assessing the absolute number of CD16+, namely, in patients with unfavorable course of MASLD, this indicator was (0.42 ± 0.15) · 109 c/L, which is 45 % higher than in the control group — (0.29 ± 0.21) · 109 c/L (p < 0.001) and 40 % higher than in patients without liver fibrosis — (0.30 ± 0.09) · 109 c/L (p < 0.001). In patients with MASLD and an immune response to SARS-CoV-2, the most significant correlations of liver parenchymal stiffness (based on SWE data) were observed with the absolute number of CD16+ cells (r = 0.568; p < 0.0001), aspartate aminotransferase levels (r = 0.503; p = 0.0001), and mean platelet volume (r = 0.513; p = 0.0001). According to the results of logistic regression analysis, the threshold values of predictors for adverse course of MASLD in patients with an immune response to SARS-CoV-2 were determined: absolute number of CD16+ more than 0.35 (sensitivity 82.1 %, specificity 92.9 %), aspartate aminotransferase level above 49 U/L (sensitivity 71.4 %, specificity 96.4 %) and MPV more than 8.5 fL (sensitivity 89.3 %, specificity 67.9 %). Conclusions. The management of patients with MASLD and an immune response to SARS-CoV-2 should include an assessment of the risk of adverse course of MASLD, which will allow for timely application of preventive and therapeutic measures to prevent the development of severe liver fibrosis and improve the quality of life of patients.

23 June 2021 in GASTROENTEROLOGY
Verified
Journal Article
Open access
PDF file
MSM.V. Stoykevich
M.V. Stoykevich
NFN.S. Fedorova
N.S. Fedorova
NNN.V. Nedzvetskaya
N.V. Nedzvetskaya
IKI.A. Klenina
I.A. Klenina
OTO.M. Tatarchuk
O.M. Tatarchuk
Background. The pathogenesis of chronic inflammatory bowel disease (IBD) is still not fully clarified. It is known that disorders of the intestinal microbiota lead to an increased intestinal permeability, activation of mucous and adaptive immunity, impaired production and intestinal absorption of short-chain fatty acids (SCFA). The ratio of acetic, propionic, butyric acids is an important indicator of the integrity of the intestinal microbial community. Thus, the study of the composition of the intestinal microbiota and the concentrations of fecal SCFA is a very promising approach to broadening the understanding of IBD pathogenesis. The purpose of our study was to determine the features of the production of fecal SCFA and the composition of colon microbiota in patients with IBD. Materials and methods. The study, which was carried out at the Department of Intestinal Diseases of the Institute of Gastroenterology of the National Academy of Medical Sciences of Ukraine, involved 74 patients with IBD with an average age of (43.2±1.8) years, who according to nosology were divided into 2 groups: group I— those with ulcerative colitis (UC) (n=66), group II— individuals with Crohn’s disease (CD) (n=8). The diagnoses of CD and UC were established according to generally accepted diagnostic standards in gastroenterology. Determination of fecal SCFA was carried out by chromatographic method with the use of hardware-software complex for medical researches on the basis of the gas chromatographer Chromateс Crystal 5000. The intestinal microflora was evaluated using a microbiological study of the colon content. Results. Patients with IBD had significant changes in the spectrum of SCFA, which were similar in both UC and CD: a decrease in acetic acid in the UC group by 5.7 times, in the CD group by 10.5 times (p<0.05), butyric acid in the UC group by 1.6 times, in the CD group by 1.5 times (p<0.05), and an increase in propionic acid in the UC group by 4 times and in the CD group by 3.3 times (p<0.05) compared with the control group. There was also a significant increase in the anaerobic index in patients with IBD. Microbiological study of feces showed a significant decrease in Lactobacillus, which was observed in all patients with IBD, as well as a decrease in Bifidobacterium in 19.7% of those with UC and in 37.5% with CD. There was a decrease of other representatives of the normal microflora: Enterococci (in 15.2% in the UC group and 25% in the CD group) and Escherichia coli (in 15.2% in the UC group and 12.5% in the CD group). Excessive growth of opportunistic flora was also detected: hemolytic Escherichia coli was increased in 19.7% of patients with UC and in 12.5% of those with CD; Proteus was detected in 12.1% of people with UC and in 37.5% with CD. The excessive growth of Candida was found in 43.9% of patients in the UC group and in 87.5% of individuals with CD. Conclusions. Quantitative and qualitative deviations of the intestinal microbiota, such as a decrease in the number of major symbionts and an increase in the number of opportunistic pathogens, were observed in all examined patients with IBD. The obtained results showed that changes in SCFA concentrations in both nosologies of IBD differed significantly from those in the control group, which in combination with primary genetic defects of the barrier function of the epithelium and its regenerative ability can lead to deterioration in the course and prognosis of IBD. Evaluation of the ratio of SCFA fractions with the calculation of the anaerobic index may be useful for the diagnosis of intestinal dysbiosis in patients with IBD.